GRAIL Q1 revenue $31.8M (+19% YoY); Galleri U.S. revenue $28.7M (+22%); net loss improves

GRAIL, Inc.

2025-Q1 EPS reported -$3.10 revenue$31,837,000

Total revenue $31.8M, up 19% YoY; U.S. Galleri revenue $28.7M, up 22% YoY.
Net loss $106.2M, improvement of $112.7M or 51% YoY; adjusted EBITDA -$98.7M.
Positive top-line results from NHS-Galleri trial; cash $677.9M provides runway into 2028.
Over 37,000 Galleri tests completed in Q1 2025; company focused on cost efficiency.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.